Azenta, Inc. (AZTA)

Market Cap	1.65B +11.8%
Revenue (ttm)	613.81M +4.8%
Net Income	-122.90M
EPS	-2.70
Shares Out	43.81M
PE Ratio	n/a
Forward PE	66.47
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,163,063
Open	35.94
Previous Close	36.00
Day's Range	35.88 - 38.34
52-Week Range	15.93 - 46.41
Beta	1.52
Analysts	Buy
Price Target	37.00 (-1.91%)
Est. Earnings	Nov 20, 2026

About AZTA

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. It operates through Sample Management Solutions and Multiomics segments. The Sample Management Solutions segment provides sample management products and services, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sampl...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Feb 1, 1995
• Employees: 2,900
• Stock Exchange: Nasdaq
• Ticker Symbol: AZTA
• Website: https://www.azenta.com

Financial Performance

In fiscal year 2025, Azenta's revenue was $593.82 million, an increase of 3.55% compared to the previous year's $573.45 million. Losses were -$55.76 million, -66.18% less than in 2024.

Analyst Summary

According to 6 analysts, the average rating for AZTA stock is "Buy." The 12-month stock price target is $37.0, which is a decrease of -1.91% from the latest price.

Price Target

$37.0

(-1.91% downside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 10, 2026

Data Sources Report a data error